OpGen

OpGen is a Maryland-based biotechnology company that researches and develops molecular diagnostic therapeutics for the treatment of infectious diseases.

Business Model:

Revenue: $3.4M

Employees: 51-200

Detailed OpGen Information

Geographic Data

OpGen headquarters map

Address: 9717 Key West Avenue

City: Rockville

State: MD

Zip: 20850

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$15M

Raised Total:

$138M

Metrics

4,521,532Website Global Rank

2,347Website Monthly Traffic

Twitter Followers

Description

OpGen is a Maryland-based biotechnology company that researches and develops molecular diagnostic therapeutics for the treatment of infectious diseases.

Contact Phone:
+13018699683

Contact Email:

OpGen went public on 4/24/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
4/24/2015

Ticker Symbol:
OPGN

IPO Price:
$5.5/share

Amount Raised:
$16M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
3/2012 BioRelix Venture Round 2.6M
3/2012 BioRelix Venture Round 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Announced Date Transaction Number of Investors Money Raised Lead Investors
2/2015 Debt Financing $1.2M
7/2015 Post-IPO Equity 1 $6M Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund
2/2018 Post-IPO Equity $12M
7/2017 Post-IPO Equity $10M
3/2019 Post-IPO Equity $5.4M
3/2012 Series C $0 180 Degree Capital
CHL Medical Partners
Cross Creek
Highland Capital Partners
jVen Capital
Versant Ventures
180 Degree Capital
CHL Medical Partners
Cross Creek
Highland Capital Partners
jVen Capital
Versant Ventures
11/2020 Post-IPO Equity $10M
10/2021 Post-IPO Equity $15M
10/2019 Post-IPO Equity $9.4M
7/2014 Debt Financing $1.1M
5/2016 Post-IPO Equity 2 $10.4M Merck Global Health Innovation Fund
Sabby Management
Merck Global Health Innovation Fund
Sabby Management
Merck Global Health Innovation Fund
Sabby Management
Merck Global Health Innovation Fund
Sabby Management
9/2010 Series B $0 CHL Medical Partners
Highland Capital Partners
jVen Capital
Mason Wells
Versant Ventures
CHL Medical Partners
Highland Capital Partners
jVen Capital
Mason Wells
Versant Ventures
1/2010 Debt Financing $4.1M
1/2023 Post-IPO Equity $7.5M
10/2022 Post-IPO Equity $3.4M
4/2020 Debt $879.6k Silicon Valley Bank
Small Business Administration
4/2020 Debt $350k U.S. Small Business Administration.
1/2023 Post-IPO Equity $7.5M
2/2012 Debt Financing $3.5M
9/2022 Post-IPO Equity $3.4M
4/2014 Debt Financing $4M
5/2010 Debt Financing $4M
1/2005 Series B $0 Mason Wells
Wisconsin Alumni Research Foundation
Stonehenge Capital
State of Wisconsin Investment Board
Mason Wells
Wisconsin Alumni Research Foundation
Stonehenge Capital
State of Wisconsin Investment Board
9/2007 Venture Round $0 Mason Wells
Versant Ventures
In-Q-Tel
Highland Capital Partners
CHL Medical Partners
Mason Wells
Versant Ventures
In-Q-Tel
Highland Capital Partners
CHL Medical Partners
Announced Date Name Price
7/2015 AdvanDx

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research